Chen et al., 2023 - Google Patents
Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics?Chen et al., 2023
View HTML- Document ID
- 8568707038658551733
- Author
- Chen H
- Yao H
- Chi J
- Li C
- Liu Y
- Yang J
- Yu J
- Wang J
- Ruan Y
- Pi J
- Xu J
- Publication year
- Publication venue
- Frontiers in Bioengineering and Biotechnology
External Links
Snippet
Chemotherapy often faces some obstacles such as low targeting effects and drug resistance, which introduce the low therapeutic efficiency and strong side effects. Recent advances in nanotechnology allows the use of novel nanosystems for targeted drug …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dessale et al. | Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis | |
| Kooijmans et al. | Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment | |
| Gurunathan et al. | A comprehensive review on factors influences biogenesis, functions, therapeutic and clinical implications of exosomes | |
| Yamamoto et al. | Latest advances in extracellular vesicles: from bench to bedside | |
| Huda et al. | Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications | |
| Ferreira et al. | New advances in exosome-based targeted drug delivery systems | |
| Du et al. | Extracellular vesicles: a rising star for therapeutics and drug delivery | |
| Wang et al. | Chemically edited exosomes with dual ligand purified by microfluidic device for active targeted drug delivery to tumor cells | |
| Kumar et al. | Exosomes as emerging drug delivery and diagnostic modality for breast cancer: recent advances in isolation and application | |
| Zhang et al. | In vivo tracking of multiple tumor exosomes labeled by phospholipid-based bioorthogonal conjugation | |
| Tanziela et al. | Efficient encapsulation of biocompatible nanoparticles in exosomes for cancer theranostics | |
| Wang et al. | Extracellular vesicles as an emerging drug delivery system for cancer treatment: Current strategies and recent advances | |
| Kim et al. | Recent advances in extracellular vesicles for therapeutic cargo delivery | |
| Araujo-Abad et al. | Biomedical application of small extracellular vesicles in cancer treatment | |
| Xu et al. | Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment | |
| Ding et al. | Improving tumor accumulation of aptamers by prolonged blood circulation | |
| Ma et al. | Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation | |
| Li et al. | A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy | |
| Chen et al. | Engineered exosomes as drug and RNA co-delivery system: new hope for enhanced therapeutics? | |
| Modani et al. | An updated review on exosomes: biosynthesis to clinical applications | |
| Mughees et al. | Exosome vesicle as a nano-therapeutic carrier for breast cancer | |
| Liu et al. | Current status, opportunities, and challenges of exosomes in oral cancer diagnosis and treatment | |
| Patel et al. | Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer | |
| Dwivedi et al. | Biochemistry of exosomes and their theranostic potential in human diseases | |
| Desai et al. | “Bioinspired” membrane-coated nanosystems in cancer theranostics: a comprehensive review |